{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T05:29:18Z","timestamp":1768022958099,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"DOI":"10.7759\/cureus.101156","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:55:25Z","timestamp":1767963325000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypercobalaminemia Leading to the Diagnosis of Retroperitoneal Paraganglioma: A Case Report"],"prefix":"10.7759","author":[{"given":"Beatriz","family":"Vit\u00f3 Madureira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"C. Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann HP","year":"2019","unstructured":"Neumann HP, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019, 381:552-65. 10.1056\/NEJMra1806651","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline","volume":"99","author":"Lenders JW","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al.. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:1915-42. 10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17061029","article-title":"Pheochromocytomas and paragangliomas\u2014current management","volume":"17","author":"Brewczy\u0144ski A","year":"2025","unstructured":"Brewczy\u0144ski A, Kolasi\u0144ska-\u0106wik\u0142a A, Jab\u0142o\u0144ska B, Wyrwicz L. Pheochromocytomas and paragangliomas\u2014current management. Cancers (Basel). 2025, 17:1029. 10.3390\/cancers17061029","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2012-0545","article-title":"Unexpected high plasma cobalamin: proposal for a diagnostic strategy","volume":"51","author":"Arendt JF","year":"2013","unstructured":"Arendt JF, Nexo E. Unexpected high plasma cobalamin: proposal for a diagnostic strategy. Clin Chem Lab Med. 2013, 51:489-96. 10.1515\/cclm-2012-0545","journal-title":"Clin Chem Lab Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S25620","article-title":"Optimal management of pernicious anemia","volume":"3","author":"Andres E","year":"2012","unstructured":"Andres E, Serraj K. Optimal management of pernicious anemia. J Blood Med. 2012, 3:97-103. 10.2147\/JBM.S25620","journal-title":"J Blood Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/nu17203272","article-title":"Vitamin B12 in cancer patients: clinical insights into deficiency, excess, diagnosis, and management","volume":"17","author":"Osmola M","year":"2025","unstructured":"Osmola M, Tyszka M, Jirka A, Ciepiela O, Kapa\u0142a A, Lenti MV, Matysiak-Budnik T. Vitamin B12 in cancer patients: clinical insights into deficiency, excess, diagnosis, and management. Nutrients. 2025, 17:3272. 10.3390\/nu17203272","journal-title":"Nutrients"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu14214476","article-title":"High plasma vitamin B12 and cancer in human studies: a scoping review to judge causality and alternative explanations","volume":"14","author":"Obeid R","year":"2022","unstructured":"Obeid R. High plasma vitamin B12 and cancer in human studies: a scoping review to judge causality and alternative explanations. Nutrients. 2022, 14:4476. 10.3390\/nu14214476","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope TA","year":"2018","unstructured":"Hope TA, Bergsland EK, Bozkurt MF, et al.. Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors. J Nucl Med. 2018, 59:66-74. 10.2967\/jnumed.117.202275","journal-title":"J Nucl Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf259","article-title":"Approach to the patient with metastatic pheochromocytoma and paraganglioma","volume":"110","author":"Alkaissi H","year":"2025","unstructured":"Alkaissi H, Taieb D, Lin FI, Del Rivero J, Wang K, Clifton-Bligh R, Pacak K. Approach to the patient with metastatic pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2025, 110:2946-63. 10.1210\/clinem\/dgaf259","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","article-title":"WHO classification of tumours of endocrine organs","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. WHO Classification of Tumours of Endocrine Organs. Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J (ed): International Agency for Research on Cancer, Lyon, France; 2017. https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Tumours-...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan A","year":"2011","unstructured":"Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, Truong LD. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011, 24:751-64. 10.1038\/modpathol.2011.3","journal-title":"Mod Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181658c14","article-title":"Sox10: a pan-schwannian and melanocytic marker","volume":"32","author":"Nonaka D","year":"2008","unstructured":"Nonaka D, Chiriboga L, Rubin BP. Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008, 32:1291-8. 10.1097\/PAS.0b013e3181658c14","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen FH","year":"2009","unstructured":"van Nederveen FH, Gaal J, Favier J, et al.. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009, 10:764-71. 10.1016\/S1470-2045(09)70164-0","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill AJ","year":"2018","unstructured":"Gill AJ. Succinate dehydrogenase (SDH)-deficient neoplasia. Histopathology. 2018, 72:106-16. 10.1111\/his.13277","journal-title":"Histopathology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15201","article-title":"Molecular markers of paragangliomas\/pheochromocytomas","volume":"8","author":"Zhikrivetskaya SO","year":"2017","unstructured":"Zhikrivetskaya SO, Snezhkina AV, Zaretsky AR, et al.. Molecular markers of paragangliomas\/pheochromocytomas. Oncotarget. 2017, 8:25756-82. 10.18632\/oncotarget.15201","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/453495-hypercobalaminemia-leading-to-the-diagnosis-of-retroperitoneal-paraganglioma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:55:26Z","timestamp":1767963326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/453495-hypercobalaminemia-leading-to-the-diagnosis-of-retroperitoneal-paraganglioma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.101156","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}